Skip to main content
Erschienen in: European Journal of Nutrition 5/2013

01.08.2013 | Original Contribution

An atherogenic diet decreases liver FXR gene expression and causes severe hepatic steatosis and hepatic cholesterol accumulation: effect of endurance training

verfasst von: Isabelle Côté, Emilienne Tudor Ngo Sock, Émile Lévy, Jean-Marc Lavoie

Erschienen in: European Journal of Nutrition | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to determine the effects of an atherogenic diet (AD; 40 % lipid, 1.25 % cholesterol, kcal) on triglyceride (TAG) and cholesterol accumulation in liver and on gene expression of liver X receptor (LXR) and farnesoid X receptor (FXR) and their target genes and to observe if these responses are affected by endurance training.

Methods

Sprague–Dawley rats (n = 32) were divided into two groups and randomly assigned to an AD or a standard diet (SD) for 7 weeks. Half of the rats in each group were assigned to an exercise training program for 5 days/week.

Results

The AD resulted in a large (P < 0.01) accumulation in liver TAG (4×) along with elevated liver and plasma cholesterol without any gain in peripheral fat mass. The liver TAG and cholesterol accumulations were associated with an important reduction (P < 0.01; 60 %) in FXR, but no change in LXR transcripts. Accompanying the reduction in FXR gene expression, we found an increase (P < 0.001) in SREBP-1c and a decrease (P < 0.01) in MTP mRNAs suggesting an increased lipogenesis and a reduced VLDL production, respectively. The AD was also associated with lower HMG-CoA-r, squalene synthase, and ABCG8 transcripts (P < 0.001). In the intestine, exercise training resulted in higher NPC1L1, ABCG5, and ABCG8 in SD-fed animals, while all these increases were suppressed under the AD feeding.

Conclusions

It is concluded that dietary cholesterol favors liver TAG and cholesterol accumulations associated with an important reduction in FXR transcripts.
Literatur
1.
Zurück zum Zitat Comhair TM, Garcia Caraballo SC, Dejong CH, Lamers WH, Kohler SE (2011) Dietary cholesterol, female gender and n-3 fatty acid deficiency are more important factors in the development of non-alcoholic fatty liver disease than the saturation index of the fat. Nutr Metab (Lond) 8:4CrossRef Comhair TM, Garcia Caraballo SC, Dejong CH, Lamers WH, Kohler SE (2011) Dietary cholesterol, female gender and n-3 fatty acid deficiency are more important factors in the development of non-alcoholic fatty liver disease than the saturation index of the fat. Nutr Metab (Lond) 8:4CrossRef
2.
Zurück zum Zitat Treguier M, Briand F, Boubacar A, Andre A, Magot T, Nguyen P, Krempf M, Sulpice T, Ouguerram K (2011) Diet-induced dyslipidemia impairs reverse cholesterol transport in hamsters. Eur J Clin Invest 41(9):921–928CrossRef Treguier M, Briand F, Boubacar A, Andre A, Magot T, Nguyen P, Krempf M, Sulpice T, Ouguerram K (2011) Diet-induced dyslipidemia impairs reverse cholesterol transport in hamsters. Eur J Clin Invest 41(9):921–928CrossRef
3.
Zurück zum Zitat Wang YM, Zhang B, Xue Y, Li ZJ, Wang JF, Xue CH, Yanagita T (2010) The mechanism of dietary cholesterol effects on lipids metabolism in rats. Lipids Health Dis 9:4CrossRef Wang YM, Zhang B, Xue Y, Li ZJ, Wang JF, Xue CH, Yanagita T (2010) The mechanism of dietary cholesterol effects on lipids metabolism in rats. Lipids Health Dis 9:4CrossRef
4.
Zurück zum Zitat Subramanian S, Goodspeed L, Wang S, Kim J, Zeng L, Ioannou GN, Haigh WG, Yeh MM, Kowdley KV, O’Brien KD et al (2011) Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice. J Lipid Res 52(9):1626–1635CrossRef Subramanian S, Goodspeed L, Wang S, Kim J, Zeng L, Ioannou GN, Haigh WG, Yeh MM, Kowdley KV, O’Brien KD et al (2011) Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice. J Lipid Res 52(9):1626–1635CrossRef
5.
Zurück zum Zitat Bhathena J, Kulamarva A, Martoni C, Malgorzata A, Malhotra UM, Paul A, Prakash S (2011) Diet-induced metabolic hamster model of nonalcoholic fatty liver disease. Diabetes Metab Syndr Obes 4:195–203 Bhathena J, Kulamarva A, Martoni C, Malgorzata A, Malhotra UM, Paul A, Prakash S (2011) Diet-induced metabolic hamster model of nonalcoholic fatty liver disease. Diabetes Metab Syndr Obes 4:195–203
6.
Zurück zum Zitat Wojcicka G, Jamroz-Wisniewska A, Horoszewicz K, Beltowski J (2007) Liver X receptors (LXRs). Part I: structure, function, regulation of activity, and role in lipid metabolism. Postepy Hig Med Dosw (Online) 61:736–759 Wojcicka G, Jamroz-Wisniewska A, Horoszewicz K, Beltowski J (2007) Liver X receptors (LXRs). Part I: structure, function, regulation of activity, and role in lipid metabolism. Postepy Hig Med Dosw (Online) 61:736–759
7.
Zurück zum Zitat Redinger RN (2003) Nuclear receptors in cholesterol catabolism: molecular biology of the enterohepatic circulation of bile salts and its role in cholesterol homeostasis. J Lab Clin Med 142(1):7–20CrossRef Redinger RN (2003) Nuclear receptors in cholesterol catabolism: molecular biology of the enterohepatic circulation of bile salts and its role in cholesterol homeostasis. J Lab Clin Med 142(1):7–20CrossRef
8.
Zurück zum Zitat Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ (1996) An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 383(6602):728–731CrossRef Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ (1996) An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 383(6602):728–731CrossRef
9.
Zurück zum Zitat Cipriani S, Mencarelli A, Palladino G, Fiorucci S (2010) FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats. J Lipid Res 51(4):771–784CrossRef Cipriani S, Mencarelli A, Palladino G, Fiorucci S (2010) FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats. J Lipid Res 51(4):771–784CrossRef
10.
Zurück zum Zitat Kong B, Luyendyk JP, Tawfik O, Guo GL (2009) Farnesoid X receptor deficiency induces nonalcoholic steatohepatitis in low-density lipoprotein receptor-knockout mice fed a high-fat diet. J Pharmacol Exp Ther 328(1):116–122CrossRef Kong B, Luyendyk JP, Tawfik O, Guo GL (2009) Farnesoid X receptor deficiency induces nonalcoholic steatohepatitis in low-density lipoprotein receptor-knockout mice fed a high-fat diet. J Pharmacol Exp Ther 328(1):116–122CrossRef
11.
Zurück zum Zitat Yang ZX, Shen W, Sun H (2010) Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease. Hepatol Int 4(4):741–748CrossRef Yang ZX, Shen W, Sun H (2010) Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease. Hepatol Int 4(4):741–748CrossRef
12.
Zurück zum Zitat Correa Antunez MI, Moran Penco JM, Amaya Lozano JL, Leal Macho A, Macia Botejara E, Saenz Santamaria J (2010) Changes in the fat composition and histomorphology of the liver after partial intestinal resections. Nutr Hosp 25(6):999–1005 Correa Antunez MI, Moran Penco JM, Amaya Lozano JL, Leal Macho A, Macia Botejara E, Saenz Santamaria J (2010) Changes in the fat composition and histomorphology of the liver after partial intestinal resections. Nutr Hosp 25(6):999–1005
13.
Zurück zum Zitat Yoshida M (2011) Novel role of NPC1L1 in the regulation of hepatic metabolism: potential contribution of ezetimibe in NAFLD/NASH treatment. Curr Vasc Pharmacol 9(1):121–123CrossRef Yoshida M (2011) Novel role of NPC1L1 in the regulation of hepatic metabolism: potential contribution of ezetimibe in NAFLD/NASH treatment. Curr Vasc Pharmacol 9(1):121–123CrossRef
14.
Zurück zum Zitat Zhu Y, Li F, Guo GL (2011) Tissue-specific function of farnesoid X receptor in liver and intestine. Pharmacol Res 63(4):259–265CrossRef Zhu Y, Li F, Guo GL (2011) Tissue-specific function of farnesoid X receptor in liver and intestine. Pharmacol Res 63(4):259–265CrossRef
15.
Zurück zum Zitat Frith J, Newton JL (2010) Liver disease in older women. Maturitas 65(3):210–214CrossRef Frith J, Newton JL (2010) Liver disease in older women. Maturitas 65(3):210–214CrossRef
16.
Zurück zum Zitat Gauthier MS, Couturier K, Latour JG, Lavoie JM (2003) Concurrent exercise prevents high-fat-diet-induced macrovesicular hepatic steatosis. J Appl Physiol 94(6):2127–2134 Gauthier MS, Couturier K, Latour JG, Lavoie JM (2003) Concurrent exercise prevents high-fat-diet-induced macrovesicular hepatic steatosis. J Appl Physiol 94(6):2127–2134
17.
Zurück zum Zitat Meissner M, Havinga R, Boverhof R, Kema I, Groen AK, Kuipers F (2010) Exercise enhances whole-body cholesterol turnover in mice. Med Sci Sports Exerc 42(8):1460–1468CrossRef Meissner M, Havinga R, Boverhof R, Kema I, Groen AK, Kuipers F (2010) Exercise enhances whole-body cholesterol turnover in mice. Med Sci Sports Exerc 42(8):1460–1468CrossRef
18.
Zurück zum Zitat Gollnick PD (1963) Chronic effect of exercise on liver cholesterol of normal and hypercholesteremic rats. Am J Physiol 205:453–456 Gollnick PD (1963) Chronic effect of exercise on liver cholesterol of normal and hypercholesteremic rats. Am J Physiol 205:453–456
19.
Zurück zum Zitat Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226(1):497–509 Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226(1):497–509
20.
Zurück zum Zitat Xu G, Pan LX, Li H, Forman BM, Erickson SK, Shefer S, Bollineni J, Batta AK, Christie J, Wang TH et al (2002) Regulation of the farnesoid X receptor (FXR) by bile acid flux in rabbits. J Biol Chem 277(52):50491–50496CrossRef Xu G, Pan LX, Li H, Forman BM, Erickson SK, Shefer S, Bollineni J, Batta AK, Christie J, Wang TH et al (2002) Regulation of the farnesoid X receptor (FXR) by bile acid flux in rabbits. J Biol Chem 277(52):50491–50496CrossRef
21.
Zurück zum Zitat Fujino T, Murakami K, Ozawa I, Minegishi Y, Kashimura R, Akita T, Saitou S, Atsumi T, Sato T, Ando K et al (2009) Hypoxia downregulates farnesoid X receptor via a hypoxia-inducible factor-independent but p38 mitogen-activated protein kinase-dependent pathway. FEBS J 276(5):1319–1332CrossRef Fujino T, Murakami K, Ozawa I, Minegishi Y, Kashimura R, Akita T, Saitou S, Atsumi T, Sato T, Ando K et al (2009) Hypoxia downregulates farnesoid X receptor via a hypoxia-inducible factor-independent but p38 mitogen-activated protein kinase-dependent pathway. FEBS J 276(5):1319–1332CrossRef
22.
Zurück zum Zitat Shi QY, Lin YG, Zhou X, Lin YQ, Yan S (2010) Expression of FXR mRNA, PPAR alpha mRNA and bile acid metabolism related genes in intrahepatic cholestasis of pregnant rats. Zhonghua Gan Zang Bing Za Zhi 18(12):927–930 Shi QY, Lin YG, Zhou X, Lin YQ, Yan S (2010) Expression of FXR mRNA, PPAR alpha mRNA and bile acid metabolism related genes in intrahepatic cholestasis of pregnant rats. Zhonghua Gan Zang Bing Za Zhi 18(12):927–930
23.
Zurück zum Zitat Zhong XY, Yu JH, Zhang WG, Wang ZD, Dong Q, Tai S, Cui YF, Li H (2012) MicroRNA-421 functions as an oncogenic miRNA in biliary tract cancer through down-regulating farnesoid X receptor expression. Gene 493(1):44–51CrossRef Zhong XY, Yu JH, Zhang WG, Wang ZD, Dong Q, Tai S, Cui YF, Li H (2012) MicroRNA-421 functions as an oncogenic miRNA in biliary tract cancer through down-regulating farnesoid X receptor expression. Gene 493(1):44–51CrossRef
24.
Zurück zum Zitat Fuchs M (2012) Non-alcoholic Fatty liver disease: the bile Acid-activated farnesoid x receptor as an emerging treatment target. J Lipids 2012:934396 Fuchs M (2012) Non-alcoholic Fatty liver disease: the bile Acid-activated farnesoid x receptor as an emerging treatment target. J Lipids 2012:934396
25.
Zurück zum Zitat Watanabe M, Houten SM, Wang L, Moschetta A, Mangelsdorf DJ, Heyman RA, Moore DD, Auwerx J (2004) Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest 113(10):1408–1418 Watanabe M, Houten SM, Wang L, Moschetta A, Mangelsdorf DJ, Heyman RA, Moore DD, Auwerx J (2004) Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest 113(10):1408–1418
26.
Zurück zum Zitat Zhang Y, Castellani LW, Sinal CJ, Gonzalez FJ, Edwards PA (2004) Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR. Genes Dev 18(2):157–169CrossRef Zhang Y, Castellani LW, Sinal CJ, Gonzalez FJ, Edwards PA (2004) Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR. Genes Dev 18(2):157–169CrossRef
27.
Zurück zum Zitat Chapados NA, Lavoie JM (2010) Exercise training increases hepatic endoplasmic reticulum (er) stress protein expression in MTP-inhibited high-fat fed rats. Cell Biochem Funct 28(3):202–210CrossRef Chapados NA, Lavoie JM (2010) Exercise training increases hepatic endoplasmic reticulum (er) stress protein expression in MTP-inhibited high-fat fed rats. Cell Biochem Funct 28(3):202–210CrossRef
28.
Zurück zum Zitat Kosters A, Frijters RJ, Schaap FG, Vink E, Plosch T, Ottenhoff R, Jirsa M, De Cuyper IM, Kuipers F, Groen AK (2003) Relation between hepatic expression of ATP-binding cassette transporters G5 and G8 and biliary cholesterol secretion in mice. J Hepatol 38(6):710–716CrossRef Kosters A, Frijters RJ, Schaap FG, Vink E, Plosch T, Ottenhoff R, Jirsa M, De Cuyper IM, Kuipers F, Groen AK (2003) Relation between hepatic expression of ATP-binding cassette transporters G5 and G8 and biliary cholesterol secretion in mice. J Hepatol 38(6):710–716CrossRef
29.
Zurück zum Zitat Yu L, Gupta S, Xu F, Liverman AD, Moschetta A, Mangelsdorf DJ, Repa JJ, Hobbs HH, Cohen JC (2005) Expression of ABCG5 and ABCG8 is required for regulation of biliary cholesterol secretion. J Biol Chem 280(10):8742–8747CrossRef Yu L, Gupta S, Xu F, Liverman AD, Moschetta A, Mangelsdorf DJ, Repa JJ, Hobbs HH, Cohen JC (2005) Expression of ABCG5 and ABCG8 is required for regulation of biliary cholesterol secretion. J Biol Chem 280(10):8742–8747CrossRef
30.
Zurück zum Zitat Lambert G, Amar MJ, Guo G, Brewer HB Jr, Gonzalez FJ, Sinal CJ (2003) The farnesoid X-receptor is an essential regulator of cholesterol homeostasis. J Biol Chem 278(4):2563–2570CrossRef Lambert G, Amar MJ, Guo G, Brewer HB Jr, Gonzalez FJ, Sinal CJ (2003) The farnesoid X-receptor is an essential regulator of cholesterol homeostasis. J Biol Chem 278(4):2563–2570CrossRef
31.
Zurück zum Zitat Gupta S, Pandak WM, Hylemon PB (2002) LXR alpha is the dominant regulator of CYP7A1 transcription. Biochem Biophys Res Commun 293(1):338–343CrossRef Gupta S, Pandak WM, Hylemon PB (2002) LXR alpha is the dominant regulator of CYP7A1 transcription. Biochem Biophys Res Commun 293(1):338–343CrossRef
32.
Zurück zum Zitat Ando H, Tsuruoka S, Yamamoto H, Takamura T, Kaneko S, Fujimura A (2005) Regulation of cholesterol 7alpha-hydroxylase mRNA expression in C57BL/6 mice fed an atherogenic diet. Atherosclerosis 178(2):265–269CrossRef Ando H, Tsuruoka S, Yamamoto H, Takamura T, Kaneko S, Fujimura A (2005) Regulation of cholesterol 7alpha-hydroxylase mRNA expression in C57BL/6 mice fed an atherogenic diet. Atherosclerosis 178(2):265–269CrossRef
33.
Zurück zum Zitat Pramfalk C, Angelin B, Eriksson M, Parini P (2007) Cholesterol regulates ACAT2 gene expression and enzyme activity in human hepatoma cells. Biochem Biophys Res Commun 364(2):402–409CrossRef Pramfalk C, Angelin B, Eriksson M, Parini P (2007) Cholesterol regulates ACAT2 gene expression and enzyme activity in human hepatoma cells. Biochem Biophys Res Commun 364(2):402–409CrossRef
34.
Zurück zum Zitat Gadaleta RM, van Mil SW, Oldenburg B, Siersema PD, Klomp LW, van Erpecum KJ (2010) Bile acids and their nuclear receptor FXR: relevance for hepatobiliary and gastrointestinal disease. Biochim Biophys Acta 1801(7):683–692CrossRef Gadaleta RM, van Mil SW, Oldenburg B, Siersema PD, Klomp LW, van Erpecum KJ (2010) Bile acids and their nuclear receptor FXR: relevance for hepatobiliary and gastrointestinal disease. Biochim Biophys Acta 1801(7):683–692CrossRef
35.
Zurück zum Zitat Alvaro A, Rosales R, Masana L, Vallve JC (2010) Polyunsaturated fatty acids down-regulate in vitro expression of the key intestinal cholesterol absorption protein NPC1L1: no effect of monounsaturated nor saturated fatty acids. J Nutr Biochem 21(6):518–525CrossRef Alvaro A, Rosales R, Masana L, Vallve JC (2010) Polyunsaturated fatty acids down-regulate in vitro expression of the key intestinal cholesterol absorption protein NPC1L1: no effect of monounsaturated nor saturated fatty acids. J Nutr Biochem 21(6):518–525CrossRef
36.
Zurück zum Zitat Levy E, Spahis S, Sinnett D, Peretti N, Maupas-Schwalm F, Delvin E, Lambert M, Lavoie MA (2007) Intestinal cholesterol transport proteins: an update and beyond. Curr Opin Lipidol 18(3):310–318CrossRef Levy E, Spahis S, Sinnett D, Peretti N, Maupas-Schwalm F, Delvin E, Lambert M, Lavoie MA (2007) Intestinal cholesterol transport proteins: an update and beyond. Curr Opin Lipidol 18(3):310–318CrossRef
37.
Zurück zum Zitat Altmann SW, Davis HR Jr, Zhu LJ, Yao X, Hoos LM, Tetzloff G, Iyer SP, Maguire M, Golovko A, Zeng M et al (2004) Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 303(5661):1201–1204CrossRef Altmann SW, Davis HR Jr, Zhu LJ, Yao X, Hoos LM, Tetzloff G, Iyer SP, Maguire M, Golovko A, Zeng M et al (2004) Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 303(5661):1201–1204CrossRef
38.
Zurück zum Zitat Durstine JL, Grandjean PW, Davis PG, Ferguson MA, Alderson NL, DuBose KD (2001) Blood lipid and lipoprotein adaptations to exercise: a quantitative analysis. Sports Med 31(15):1033–1062CrossRef Durstine JL, Grandjean PW, Davis PG, Ferguson MA, Alderson NL, DuBose KD (2001) Blood lipid and lipoprotein adaptations to exercise: a quantitative analysis. Sports Med 31(15):1033–1062CrossRef
39.
Zurück zum Zitat Meissner M, Havinga R, Boverhof R, Kema I, Groen AK, Kuipers F (2010) Exercise enhances whole-body cholesterol turnover in mice. Med Sci Sports Exerc 42(8):1460–1468CrossRef Meissner M, Havinga R, Boverhof R, Kema I, Groen AK, Kuipers F (2010) Exercise enhances whole-body cholesterol turnover in mice. Med Sci Sports Exerc 42(8):1460–1468CrossRef
40.
Zurück zum Zitat Wilund KR, Feeney LA, Tomayko EJ, Weiss EP, Hagberg JM (2009) Effects of endurance exercise training on markers of cholesterol absorption and synthesis. Physiol Res 58(4):545–552 Wilund KR, Feeney LA, Tomayko EJ, Weiss EP, Hagberg JM (2009) Effects of endurance exercise training on markers of cholesterol absorption and synthesis. Physiol Res 58(4):545–552
41.
Zurück zum Zitat Meissner M, Lombardo E, Havinga R, Tietge UJ, Kuipers F, Groen AK (2011) Voluntary wheel running increases bile acid as well as cholesterol excretion and decreases atherosclerosis in hypercholesterolemic mice. Atherosclerosis 218(2):323–329CrossRef Meissner M, Lombardo E, Havinga R, Tietge UJ, Kuipers F, Groen AK (2011) Voluntary wheel running increases bile acid as well as cholesterol excretion and decreases atherosclerosis in hypercholesterolemic mice. Atherosclerosis 218(2):323–329CrossRef
42.
Zurück zum Zitat Gauthier MS, Favier R, Lavoie JM (2006) Time course of the development of non-alcoholic hepatic steatosis in response to high-fat diet-induced obesity in rats. Br J Nutr 95(2):273–281CrossRef Gauthier MS, Favier R, Lavoie JM (2006) Time course of the development of non-alcoholic hepatic steatosis in response to high-fat diet-induced obesity in rats. Br J Nutr 95(2):273–281CrossRef
43.
Zurück zum Zitat Basciano H, Miller AE, Naples M, Baker C, Kohen R, Xu E, Su Q, Allister EM, Wheeler MB, Adeli K (2009) Metabolic effects of dietary cholesterol in an animal model of insulin resistance and hepatic steatosis. Am J Physiol Endocrinol Metab 297(2):E462–E473CrossRef Basciano H, Miller AE, Naples M, Baker C, Kohen R, Xu E, Su Q, Allister EM, Wheeler MB, Adeli K (2009) Metabolic effects of dietary cholesterol in an animal model of insulin resistance and hepatic steatosis. Am J Physiol Endocrinol Metab 297(2):E462–E473CrossRef
44.
Zurück zum Zitat Matsuzawa N, Takamura T, Kurita S, Misu H, Ota T, Ando H, Yokoyama M, Honda M, Zen Y, Nakanuma Y et al (2007) Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology 46(5):1392–1403CrossRef Matsuzawa N, Takamura T, Kurita S, Misu H, Ota T, Ando H, Yokoyama M, Honda M, Zen Y, Nakanuma Y et al (2007) Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology 46(5):1392–1403CrossRef
45.
Zurück zum Zitat Yiu WF, Kwan PL, Wong CY, Kam TS, Chiu SM, Chan SW, Chan R (2011) Attenuation of fatty liver and prevention of hypercholesterolemia by extract of Curcuma longa through regulating the expression of CYP7A1, LDL-receptor, HO-1, and HMG-CoA reductase. J Food Sci 76(3):H80–H89CrossRef Yiu WF, Kwan PL, Wong CY, Kam TS, Chiu SM, Chan SW, Chan R (2011) Attenuation of fatty liver and prevention of hypercholesterolemia by extract of Curcuma longa through regulating the expression of CYP7A1, LDL-receptor, HO-1, and HMG-CoA reductase. J Food Sci 76(3):H80–H89CrossRef
46.
Zurück zum Zitat Koopmans SJ, Dekker R, Ackermans MT, Sauerwein HP, Serlie MJ, van Beusekom HM, van den Heuvel M, van der Giessen WJ (2011) Dietary saturated fat/cholesterol, but not unsaturated fat or starch, induces C-reactive protein associated early atherosclerosis and ectopic fat deposition in diabetic pigs. Cardiovasc Diabetol 10:64CrossRef Koopmans SJ, Dekker R, Ackermans MT, Sauerwein HP, Serlie MJ, van Beusekom HM, van den Heuvel M, van der Giessen WJ (2011) Dietary saturated fat/cholesterol, but not unsaturated fat or starch, induces C-reactive protein associated early atherosclerosis and ectopic fat deposition in diabetic pigs. Cardiovasc Diabetol 10:64CrossRef
47.
Zurück zum Zitat Zhang Y, Ge X, Heemstra LA, Chen WD, Xu J, Smith JL, Ma H, Kasim N, Edwards PA, Novak CM (2012) Loss of FXR protects against diet-induced obesity and accelerates liver carcinogenesis in ob/ob mice. Mol Endocrinol 26(2):272–280CrossRef Zhang Y, Ge X, Heemstra LA, Chen WD, Xu J, Smith JL, Ma H, Kasim N, Edwards PA, Novak CM (2012) Loss of FXR protects against diet-induced obesity and accelerates liver carcinogenesis in ob/ob mice. Mol Endocrinol 26(2):272–280CrossRef
48.
Zurück zum Zitat Prawitt J, Abdelkarim M, Stroeve JH, Popescu I, Duez H, Velagapudi VR, Dumont J, Bouchaert E, van Dijk TH, Lucas A et al (2011) Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity. Diabetes 60(7):1861–1871CrossRef Prawitt J, Abdelkarim M, Stroeve JH, Popescu I, Duez H, Velagapudi VR, Dumont J, Bouchaert E, van Dijk TH, Lucas A et al (2011) Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity. Diabetes 60(7):1861–1871CrossRef
Metadaten
Titel
An atherogenic diet decreases liver FXR gene expression and causes severe hepatic steatosis and hepatic cholesterol accumulation: effect of endurance training
verfasst von
Isabelle Côté
Emilienne Tudor Ngo Sock
Émile Lévy
Jean-Marc Lavoie
Publikationsdatum
01.08.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nutrition / Ausgabe 5/2013
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-012-0459-5

Weitere Artikel der Ausgabe 5/2013

European Journal of Nutrition 5/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.